Medical Spa Insider

This week, AmSpa CEO, Alex R. Thiersch, JD, speaks with Taylor Siemens, NP-C, founder of Aesthetic Care NP and clinical director of Vitalyc Medspa. They discuss medical weight loss programs and protocols for offering semaglutide in your aesthetic practice. Their conversation includes:

• Semaglutide’s history and current usage;
• Controversy over supply and compounding;
• Determining whether someone is a candidate for the medication;
• Following FDA guidelines and designing a protocol;
• Health screening, follow-up and monitoring patients on this medication;
• Mechanism of action and potential side effects of semaglutide;
• And more!

Read more about the ongoing lawsuits filed by Novo Nordisk, maker of Ozempic and Wegovy, at the AmSpa Now blog. Stay tuned for new updates on the subject as more info becomes available.

This episode of Medical Spa Insider is sponsored by RepeatMD. Visit https://www.repeatmd.com/ to learn more!